Professional-grade aesthetic booster designed for in-clinic microneedling treatments…
Medik8 introduces Exo-PDRN Prismatic+ Pro Concentrate, a professional-use skincare formulation developed to support in-clinic microneedling procedures and post-treatment skin recovery.
Rooted in advanced skin biology, the formula combines prismatic PDRN, a triple exosome complex, and Dual MiniProteins™ to work synergistically with the skin’s natural recovery processes. Designed exclusively for professional aesthetic use, it aims to support visible improvements in skin texture, firmness, and overall resilience following microneedling treatments.
The formulation is intended for use during and immediately after in-clinic procedures, with continued application recommended for short-term post-treatment support.
Key Ingredients
- Prismatic PDRN (Vegan DNA Complex) - A vegan-derived PDRN composed of DNA particles with a stable tetrahedral structure, designed to support skin recovery processes and help improve the appearance of post-treatment redness.
- Triple Exosome Complex - A multi-layered exosome-inspired system that supports skin signalling processes associated with resilience and recovery, helping to reinforce the appearance of a strengthened skin barrier.
- Expression Line MiniProtein™ - A biomimetic protein designed to help reduce the appearance of dynamic expression lines, supporting a smoother-looking complexion.
- GF MiniProtein™ - A growth factor-inspired microprotein engineered to support visible improvements in skin structure and refinement over time.
Clinical Studies
Clinically proven to enhance in-clinic microneedling results*:
- 8.2x BOOSTED visible wrinkle reduction
- 3.6x GREATER barrier support
- 7.5x BOOSTED visible firmness
- 2.6x ENHANCED visible brightening
- 5.3x BOOSTED visible elasticity
- 2.1x IMPROVEMENT in skin texture
For professional enquiries, clinics and practitioners can contact their HealthXchange sales representative for product availability, training information and ordering details.
*Proven via independent clinical study using Exo-PDRN Prismatic+ Pro Concentrate combined with microneedling on 25 volunteers over 4 weeks, using split-face method measuring relative improvement compared to microneedling treatment alone.